Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05407168 · ClinicalTrials.gov registry record · NA
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
A NA study of Lung Carcinoma, sponsored by OHSU Knight Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 4
- Study locations
NCT05407168: Recruiting NA study of Lung Carcinoma, sponsored by OHSU Knight Cancer Institute.
NCT05407168 is a NA study of Lung Carcinoma that is actively recruiting participants, run by OHSU Knight Cancer Institute. The registered enrollment target is 300 participants, below the 5,036-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (94% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05407168, a NA study of Lung Carcinoma, is actively recruiting participants, sponsored by OHSU Knight Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 4
- Study locations
Study Summary
This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.
Primary Outcome
Will be assessed using the Decisional Conflict Scale, which contains 16 items. Higher scores indicate higher decisional conflict.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Best Practice
- OTHER Health Promotion and Education
Study Locations (4)
Oregon
- Hillsboro Medical Center - Hillsboro
- Adventist Health Portland - Portland
- OHSU Knight Cancer Institute - Portland
- Portland VA Medical Center - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2022-10-31 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT05407168 shows while recruiting
NCT05407168 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 5,036-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Lung Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT05407168 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT05407168 about?
NCT05407168 is a clinical study titled "Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool". This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared d...
What is the current status of trial NCT05407168?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-10-31. Estimated completion is 2027-12-31.
What conditions does trial NCT05407168 study?
This clinical trial studies the following conditions: Lung Carcinoma.
What interventions are being tested in trial NCT05407168?
The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Health Promotion and Education (OTHER).
Who is sponsoring clinical trial NCT05407168?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05407168 being conducted?
This trial has 4 study locations across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05407168's enrollment target sits among peer trials
300 12th of 38 higher than 27 of 38 other Lung Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
CONNECTing to LungCare
RECRUITING · NA
-
Engagement of Veterans With Lung Cancer
RECRUITING · NA
-
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
RECRUITING · NA
-
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
RECRUITING · NA
-
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI